Issue 77, 2022

A photo-activated aptamer–drug conjugate for targeted drug delivery

Abstract

A photo-activated aptamer–drug conjugate, HG1-9–DNP, was developed based on an aptamer HG1-9 and a photolabile naphthalimide derivative DNP. HG1-9–DNP could be internalized into cells mediated by TfR, then photocleaved, and released a promising cytotoxic agent, DNNH, which arrested the cell cycle at the G2/M phase, resulting in high photo-induced cytotoxicity.

Graphical abstract: A photo-activated aptamer–drug conjugate for targeted drug delivery

Supplementary files

Article information

Article type
Communication
Submitted
20 Jul 2022
Accepted
30 Aug 2022
First published
30 Aug 2022

Chem. Commun., 2022,58, 10797-10800

A photo-activated aptamer–drug conjugate for targeted drug delivery

J. Liu, X. Liu, M. Yi, Y. Sun, T. Bing, N. Zhang and D. Shangguan, Chem. Commun., 2022, 58, 10797 DOI: 10.1039/D2CC04045J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements